Mirae Asset Global ETFs Holdings’s ADMA Biologics ADMA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Buy	131,340 +4,168	+3%	+$38K	﹤0.01%	1595
2026 Q1	$1.15M	Buy	127,172 +2,435	+2%	+$38.4K	﹤0.01%	1455
2025 Q4	$2.28M	Sell	124,737 -1,182	-0.9%	-$19.9K	﹤0.01%	1096
2025 Q3	$1.85M	Sell	125,919 -14,147	-10%	-$243K	﹤0.01%	1178
2025 Q2	$2.55M	Sell	140,066 -7,099	-5%	-$145K	﹤0.01%	994
2025 Q1	$2.92M	Sell	147,165 -1,473	-1%	-$25.5K	0.01%	945
2024 Q4	$2.56M	Buy	148,638 +10,047	+7%	+$189K	0.01%	1001
2024 Q3	$2.76M	Buy	138,591 +20,672	+18%	+$321K	0.01%	963
2024 Q2	$1.32M	Buy	+117,919	New	+$989K	﹤0.01%	1306

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ADMA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its ADMA Biologics (ADMA) stake by 3.3% in Q2 2026, buying an estimated $38K and bringing the position to 131,340 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

Mirae Asset Global ETFs Holdings first reported a position in ADMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.92M in Q1 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Mirae Asset Global ETFs Holdings held 131,340 shares of ADMA Biologics worth $1.1M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 4,168 ADMA Biologics shares in Q2 2026, an estimated $38K.
ADMA Biologics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1595 holding.
Mirae Asset Global ETFs Holdings first reported a position in ADMA Biologics in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's ADMA Biologics position peaked at $2.92M in Q1 2025.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.